J. Rhie

发表

Drug Marker Absorption in Relation to Pellet Size, Gastric Motility and Viscous Meals in Humans

Jeremy J. Frens, G. Amidon, G. Amidon, 1998, Pharmaceutical Research.

CHAPTER 17 – RELEVANCE OF PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TO PHASE I TRIAL EXTRAPOLATION TECHNIQUES: RELEVANCE OF ANIMAL TOXICOLOGY

J. Rhie, J. Tomaszewski, J. Covey, 2002 .

5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter

Wolfgang Sadee, W. Sadee, Chao-pin Lee, 1998, Pharmaceutical Research.

Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents

Hui Wang, Ruiwen Zhang, D. Hockenbery, 2005, Cancer Chemotherapy and Pharmacology.

Drug delivery of oral anti-cancer fluoropyrimidine agents

M. Kinouchi, R. Katakura, M. Unno, 2017, Expert opinion on drug delivery.

Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent

Hui Wang, Ruiwen Zhang, L. Nan, 2005, Cancer Chemotherapy and Pharmacology.

Determination of desoxyepothilone B in nude mice plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.

Hui Wang, Ruiwen Zhang, L. Nan, 2006, Journal of pharmaceutical and biomedical analysis.

Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats

V. Gandhi, R. Newman, T. Madden, 2002, Cancer Chemotherapy and Pharmacology.

Human Intestinal Permeability of Piroxicam, Propranolol, Phenylalanine, and PEG 400 Determined by Jejunal Perfusion

G. Amidon, L. Lesko, H. Lennernäs, 1997, Pharmaceutical Research.

Radiolabeled 2′-fluorodeoxyuracil-β-D-arabinofuranoside (FAU) and 2′-fluoro-5-methyldeoxyuracil-β-D-arabinofuranoside (FMAU) as tumor-imaging agents in mice

Hui Wang, Ruiwen Zhang, P. Oliver, 2002, Cancer Chemotherapy and Pharmacology.

The effect of aging on the dissolution of wet granulated tablets containing super disintegrants

J. Rhie, Marc S. Gordon, Varma S. Rudraraju, 1993 .

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.

G. Amidon, J. Rhie, D. Oh, 1999, Journal of pharmaceutical sciences.

Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.

Hui Wang, Ruiwen Zhang, P. Oliver, 2002, Cancer chemotherapy and pharmacology.